NCEL — NewcelX Ltd.
$2.66+3.91%
Last close: · regular session
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for NCEL in the TickerWise workspace.
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: CH
- Exchange: NASDAQ Capital Market
- Employees: 11
- Website: https://www.newcelx.com
Latest SEC filings for NCEL
Latest NCEL news
- NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.